Changes in physiology with increasing fat mass

Seminars in Pediatric Surgery

Volumn 18, Issue 3, 2009, Pages 126-135

  Schuster, Dara P ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Adipose tissue; Hormones; Obesity

Indexed keywords

BIOLOGICAL MARKER; HORMONE; INSULIN;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BODY FAT; CHILDHOOD DISEASE; COMORBIDITY; DYSLIPIDEMIA; ENERGY EXPENDITURE; GASTROINTESTINAL TRACT; GENETIC SUSCEPTIBILITY; GROWTH DISORDER; HORMONAL REGULATION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MATURATION; METABOLIC DISORDER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORTHOPEDICS; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROME; STEATOSIS; UNITED STATES;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ADOLESCENT; ANIMALS; BODY MASS INDEX; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCRETINS; METABOLIC SYNDROME X; OBESITY; OHIO; POLYCYSTIC OVARY SYNDROME; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 67649311631     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2009.04.002     Document Type: Article

References (97)

1. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. J Am Med Assoc 288 (2002) 1723-1727
2. Kimm Y.S., and Obarzanek E. Childhood obesity: A new pandemic for the new millennium. Pediatrics 110 (2002) 1003-1007
3. Kirn T.F. Worldwide survey finds adult obesity rate of around 25%. Circulation (2007) epub doi 10.1161/circulationaha.106.676379.
4. Must A., Jacques P.F., Dallal G.I., et al. Long-term morbidity and mortality of overweight adolescents. N Engl J Med 327 (1992) 1350-1355
5. Rodeheffer M.S., Birsoy K., and Friedman J.M. Identification of white adipocyte progenitor cells in vivo. Cell 135 (2008) 240-249
6. Leibel R., Berry E., and Hirsch J. Biochemistry and development of adipose tissue in man. In: Conn Jr. H.L., DeFelice E.A., and Kuo P. (Eds). Health and Obesity (1983), Raven Press, New York, NY
7. Tang W., Zeve D., and Suh J. White fat progenitor cells reside in the adipose vasculature. Science 322 (2008) 583-586
8. Knittle J., Timmers K., Ginsberg-Fellner F., et al. The growth of adipose tissue in children and adolescents. J Clin Invest 63 (1979) 239-246
9. Ailhaud G. Adipose cell differentiation in culture. Mol Cell Biochem 49 (1982) 17-31
10. Adams M., Montague C.T., Prins J.B., et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100 (1997) 3149-3153
11. Kissebah A.H., Vydelingum N., Murray M., et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol 54 (1982) 254-260
12. Leibel R.L., Rosenbaum M., and Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 332 (1995) 621
13. Leibel R.L., and Hirsch J. Diminished energy requirements in reduced-obese patients. Metabolism 33 (1984) 164
14. Bray G.A., Fisler J., and York D.A. Neuroendocrine control of the development of obesity: Understanding gained from studies of experimental animal models. Front Neuroendocrinol 11 (1990) 128
15. Rankinen T., Perusse L., Weisnagel S.J., et al. The human obesity gene map: The 2001 update. Obes Res 10 (2002) 196
16. Shutter J.R., Graham M., Kinsey A.C., et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11 (1997) 593
17. Katsuki A., Sumida Y., Gabazza E.C., et al. Plasma levels of agouti-related protein are increased in obese men. J Clin Endocrinol Metab 86 (2001) 1921
18. Zhang Y.Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homolog. Nature 372 (1994) 425
19. Campfield L.A., Smith F.J., and Burn P. The OB protein (leptin) pathway: A link between adipose tissue mass and central neural networks. Horm Metab Res 28 (1996) 619
20. Chen H., Charlat O., Tartaglia L.A., et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84 (1996) 491
21. Schwartz M.W., Seeley R.J., Campfield L.A., et al. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98 (1996) 1101
22. Bray G.A., and York D.A. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 82 (1997) 2771
23. Gerald C., Walker M.W., Criscione L., et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382 (1996) 168
24. Farooqi I.S., Jebb S.A., Langmack G., et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341 (1999) 879
25. Clement K., Vaisse C., Lahlou N., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998) 398
26. Saad M.F., Riad-Gabriel M.G., Khan A., et al. Diurnal and ultradian rhythmicity of plasma leptin: Effects of gender and adiposity. J Clin Endocrinol Metab 83 (1998) 453
27. Bouchard C., Despres J.P., and Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 14 (1993) 72
28. Stunkard A.J., Sorensen T.I., Hanis C., et al. An adoption study of human obesity. N Engl J Med 314 (1986) 193
29. Wardle J., Carnell S., Haworth C.M.A., et al. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr 87 (2008) 398-404
30. Woods S.C., Seeley R.J., and Porte Jr. D. Signals that regulate food intake and energy homeostasis. Science 280 (1998) 1378-1383
31. Parfrey P.S., Davidson W.S., and Green J.S. Clinical and genetic epidemiology of inherited renal disease in Newfoundland. Kidney Int 61 (2002) 1925
32. Fontaine E., Savard R., Tremblay A., et al. Resting metabolic rate in monozygotic and dizygotic twins. Acta Genet Med Gemellol (Roma) 34 (1985) 41
33. Bouchard C., Tremblay A., Despres J.P., et al. The response to long-term overfeeding in identical twins. N Engl J Med 322 (1990) 1477
34. Ravussin E., Lillioja S., Knowler W.C., et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 318 (1988) 467
35. Weisnsier R.L., Hunter G.R., Heini A.F., et al. The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity. Am J Med 105 (1998) 145-150
36. Perusse L., Tremblay A., Lablanc C., et al. Genetic and environmental influences on level of habitual physical activity and exercise participation. Am J Epidemiol 129 (1989) 1012-1022
37. Engeli S., Feldpaussch M., Gorzelniak K., et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
38. Straczkowski M.A., Kowalska I., Stepien A., et al. Increased plasma-soluble tumor necrosis factor alpha-receptors level in lean, nondiabetic offspring of type 2 diabetic subjects. Diabetes Care 25 (2002) 1824-1828
39. Krakoff J., Funahaser T., Stenhouwer C.D.A., et al. Inflammatory markers, adiponectin and the risk of type 2 diabetes in the Pima Indians. Diabetes Care 26 (2003) 1745-1751
40. Sprangler J., Kroke A., Mohlig M., et al. Adiponectin and protection against type 2 diabetes. Lancet 361 (2003) 226-228
41. Foster G.D., Wadden T.A., Mullen J.L., et al. Resting energy expenditure, body composition and excess weight in the obese. Metabolism 37 (1988) 467-472
42. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 344 (1996) 292
43. Griffen W.O., Bivins B.A., Bell R.M., et al. Gastric bypass for morbid obesity. World J Surg 5 (1981) 817-822
44. Hickey M.S., Pories W.J., MacDonald K.G., et al. A new paradigm for type 2 diabetes mellitus: Could it be a disease of the foregut?. Ann Surg 227 (1998) 637-644
45. Cummings D.E., Weigle D.S., Frayo R.S., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623
46. Foster-Schubert K.E., McTiernan A., Frayo R.S., et al. Human plasma ghrelin levels increase during a one-year exercise program. J Clin Endocrinol Metab 90 (2005) 820
47. Taylor I.L. Role of peptide YY in the endocrine control of digestion. J Dairy Sci 76 (1993) 2094-2101
48. Batterham R.L., Cohen M.A., Ellis S.M., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 (2003) 941-948
49. Korner J., Bessler M., Cirilo L.J., et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 90 (2005) 359-365
50. Kellum J.M., Kuemmerle J.F., O'Dorisio T.M., et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 211 (1990) 763-770
51. Naslund E., Backman L., Holst J.J., et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 8 (1998) 253-260
52. Sarson D.L., Scopinaro N., and Bloom S.R. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 5 (1981) 471-480
53. Druce M.R., Small C.J., and Bloom S.R. Minireview: Gut peptides regulating satiety. Endocrinology 145 (2004) 2660-2665
54. Verdich C., Toubro S., Buemann B., et al. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety: Effect of obesity and weight reduction. Int J Obes Relat Metab Disord 25 (2001) 1206-1214
55. Velasquez-Mieyer P.A., Cowan P.A., Umpierrez G.E., et al. Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects. Int J Obes Relat Metab Disord 27 (2003) 1359-1364
56. Feinle C., Chapman I.M., Wishart J., et al. Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men. Peptides 23 (2002) 1491-1495
57. Pappas T.N. Physiological satiety implications of gastrointestinal antiobesity surgery. Am J Clin Nutr 55 (2002) 571S-572S
58. Schauer P.R., Burguera B., Ikramuddin S., et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238 (2003) 467-485
59. Sugerman H.J., Wolfe L.G., Sica D.A., et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237 (2003) 751-758
60. Wittgrove A.C., and Clark G.W. Laparoscopic gastric bypass, Roux-en-Y 500 patients: Technique and results, with 3-60-month follow-up. Obes Surg 10 (2000) 233-239
61. Schauer P.R., Ikramuddin S., Gourash W., et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232 (2000) 515-529
62. Zander M., Madsbad S., Madsen J.L., et al. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359 (2002) 824-830
63. Zhang J.V., Ren P.G., Avsian-Kretchmer O., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
64. Del Prato S., Enzi G., Vigili de Kreutzenberg S., et al. Insulin regulation of glucose and lipid metabolism in massive obesity. Diabetologia 33 (1990) 228-236
65. Lillioja S., Foley J., Bogardus C., et al. Free fatty acid metabolism and obesity in Man: in vivo and in vitro comparisons. Metabolism 35 (1986) 505-514
66. Polonsky K.S., Given B.D., Lirsch L., et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81 (1988) 435-441
67. Monti L.D., Brambilla P., Stefani I., et al. Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. Diabetologia 38 (1995) 739-747
68. LeStunff C., and Bourgeres P. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 43 (1994) 696-702
69. Giusti V., Suter M., Heraief E., et al. Effects of laparoscopic gastric banding on body composition, metabolic profile and nutritional status of obese women: 12-month follow-up. Obes Surg 14 (2004) 239-245
70. Busetto L., Tregnaghi A., Bussolotto M., et al. Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparoscopic adjustable silicone gastric banding. Int J Obes 24 (2000) 60-69
71. Goodpaster B.H. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46 (1997) 1579-1585
72. Olshansky S.J., Passaro D.J., Hershow R.C., et al. Potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352 (2005) 1138-1145
73. Gastrointestinal surgery for severe obesity. Proceedings of a National Institutes of Health Consensus Development Conference. March 25-27, 1991, Bethesda, MD. Am J Clin Nutr 55 suppl (1992) 487S-619S
74. Long S.D., O'Brien K., MacDonald Jr. K.G., et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 17 5 (1994) 372-375
75. Dixon J.B., Dixon A.F., and O'Brien P.E. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med 20 2 (2003) 127-134
76. Garn S.M., LaVelle M., Rosenberg K.R., et al. Maturational timing as a factor in female fatness and obesity. Am J Nutr 43 (1986) 879-883
77. Van Lenthe F.J., Kemper H.C.G., van Mecehelen W., et al. Biological maturation and the distribution of subcutaneous fat from adolescence into adulthood: the Amsterdam Growth and Health study. Int J Obes 20 (1996) 121-129
78. Kelsey J.L., Keggi K.J., and Southwick W.O. The incidence and distribution of slipped femoral epiphysis in Connecticut and southwestern United States. J Bone Joint Surg 52A (1970) 1203-1216
79. Pinhas-Hamiel O., Dolan L.M., Daniels S.R., et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 128 (1996) 608-615
80. Richards G.E., Cavallo A., Meyer III W.J., et al. Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history. J Pediatr 107 (1985) 893-897
81. Rhodes S.K., Shimoda K.C., Waid L.R., et al. Neurocognitive deficits in morbidly obese children with obstructive sleep apnea. J Pediatr 127 (1995) 741-744
82. Suarez E.C. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 22 (2008) 960-968
83. Bonnet M.H., Berry R.B., and Arand D.L. Metabolism during normal, fragmented, and recovery. J Appl Physiol 71 (1991) 1112-1118
84. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897-1904
85. Meslier N., Gagnadoux P., Giraud C., et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnea syndrome. Eur Respir J 22 (2003) 156-160
86. Lauer R.M., Connor W.E., Leaverton P.E., et al. Coronary heart disease risk factors in school children: The Muscatine study. J Pediatr 86 (1975) 697-706
87. Finta K.M., Rocchini A.P., Moorehead C., et al. Urine sodium excretion in response to an oral glucose tolerance test in obese and nonobese adolescents. Pediatrics 90 (1992) 442-446
88. Rocchini A.P., Katch V., Anderson J., et al. Blood pressure in obese adolescents: Effect of weight loss. Pediatrics 82 (1988) 16-23
89. Fabbrini E., deHaseth D., Deivanayagam D., et al. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity 17 (2008) 25-29
90. Ehrmann D.A., Barnes R.B., Rosenfield R.L., et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1999) 141-146
91. Freedman D.S., Srinivasan S.R., Harsha D.W., et al. Relation of body fat patterning to lipid and lipoprotein concentrations in children and adolescents: The Bogalusa Heart Study. Am J Clin Nutr 50 (1989) 930-939
92. Steinberger J., Moorehead C., Katch V., et al. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 126 (1995) 690-695
93. Caprio S., Hyman L.D., Limb C., et al. Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 269 (1995) E118-E126
94. Shimomura I., Funahashi T., Takahashi M., et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2 (1996) 800-803
95. Eriksson P., Reynisdottir S., Lonnqvist F., et al. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 41 (1998) 65-71
96. Stefan N., Kantartzis K., Machann J., et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168 (2008) 1609-1616
97. Gortmaker S.L., Must A., Perrin J.M., et al. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 329 (1993) 1008-1012